ArticleNeuro-oncology advances

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma.

Uday P Pratap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.